LUCID DIAGNOSTICS INC's ticker is and the CUSIP is 54948X109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $185,018 | -33.1% | 158,135 | -20.6% | 0.02% | -40.7% |
| Q2 2023 | $276,713 | -26.6% | 199,074 | -23.9% | 0.03% | -6.9% |
| Q1 2023 | $376,796 | -0.9% | 261,664 | -6.4% | 0.03% | +16.0% |
| Q4 2022 | $380,170 | -13.2% | 279,537 | -2.4% | 0.02% | -10.7% |
| Q3 2022 | $438,000 | -37.2% | 286,432 | -7.3% | 0.03% | -20.0% |
| Q2 2022 | $698,000 | -34.2% | 308,978 | -2.0% | 0.04% | -25.5% |
| Q1 2022 | $1,060,000 | -54.6% | 315,414 | -27.5% | 0.05% | -42.7% |
| Q4 2021 | $2,336,000 | – | 435,055 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 73,907 | $86,471 | 0.59% |
| LUMINUS MANAGEMENT LLC | 875,100 | $1,023,867 | 0.32% |
| Nantahala Capital Management | 158,135 | $185,018 | 0.02% |
| Byrne Asset Management LLC | 7,210 | $8,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 135,000 | $157,950 | 0.00% |
| Geneos Wealth Management Inc. | 33,850 | $39,605 | 0.00% |
| UBS Group AG | 5,516 | $6,454 | 0.00% |
| VANGUARD GROUP INC | 325,566 | $380,912 | 0.00% |
| OSAIC HOLDINGS, INC. | 2,000 | $2,340 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 174 | $204 | 0.00% |